Prospective Evaluation of a Commercially Available Hydrogel Spacer

Completed

Conditions studied: Prostate Cancer

In brief

Dosimetry efficacy evaluation of the hydrogel spacer

Key facts

Study ID

NCT05323747

Run by

BioProtect

People needed

20

Starts

2020-11-20

Expected to finish

2022-02-08

Last updated by the study team

2025-09-16

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Males
• At lease 18 years of age
• Undergoing external beam or brachy radiation therapy with a hydrogel spacer

You may not qualify if…

• Invasive adenocarcinoma that is extracapsular and demonstrates posterior extension

Where it is running

• Western Radiation Oncology — Campbell, California, United States
• Northern Nevada Radiation Oncology — Reno, Nevada, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.